NCT07182110View on ClinicalTrials.gov

Dexamethasone-Enhanced TAP Block in Lapchole

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Laparoscopic Cholecystectomy
Interventions
DRUG

Dexamethasone enhanced TAP Block

20 ml Marcaine containing 0.25% bupivacaine + 4 mg dexamethasone + normal saline

DRUG

Marcaine- 0.25%

20 ml solution containing 0.25% bupivacaine + normal saline

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER